IRIS
FONTI, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 918
EU - Europa 423
AS - Asia 146
AF - Africa 42
OC - Oceania 1
Totale 1.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 898
IT - Italia 177
CN - Cina 125
IE - Irlanda 48
UA - Ucraina 45
FI - Finlandia 43
CI - Costa d'Avorio 42
NL - Olanda 32
SE - Svezia 27
DE - Germania 23
CA - Canada 20
GB - Regno Unito 14
VN - Vietnam 6
BE - Belgio 4
HK - Hong Kong 4
IN - India 4
RU - Federazione Russa 3
SG - Singapore 3
SK - Slovacchia (Repubblica Slovacca) 3
IS - Islanda 2
AU - Australia 1
DK - Danimarca 1
FR - Francia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
Totale 1.530
Salva come PNG Salva come JPEG
Città #
Chandler 212
Millbury 60
Jacksonville 55
Naples 52
Princeton 47
Boston 41
Ashburn 37
Nanjing 37
Amsterdam 32
Woodbridge 27
Beijing 26
Des Moines 24
Napoli 22
Wilmington 20
Ottawa 19
Lawrence 13
Hebei 12
Nanchang 12
Milan 9
Tianjin 9
Shenyang 8
Falls Church 7
Changsha 6
Dong Ket 6
Dublin 6
Kronberg 6
Dearborn 5
Norwalk 5
Seattle 5
Boardman 4
Courcelles 4
Jiaxing 4
Bratislava 3
Caserta 3
Giugliano in Campania 3
Hangzhou 3
Bacoli 2
Cava 2
Hong Kong 2
Lappeenranta 2
Milazzo 2
Nocera Inferiore 2
Osimo 2
Portici 2
Reykjavik 2
San Francisco 2
Tolentino 2
Venezia 2
Washington 2
Zhengzhou 2
Ann Arbor 1
Arezzo 1
Avigliano 1
Bloomfield 1
Casoria 1
Castel Volturno 1
Changchun 1
Copenhagen 1
Denpasar 1
Edinburgh 1
Fairfield 1
Forlì 1
Genova 1
Indiana 1
Kunming 1
Lanzhou 1
Los Angeles 1
Magdeburg 1
Mcallen 1
Melfi 1
Mestre 1
Monza 1
New York 1
Norwich 1
Orange 1
Palermo 1
Piemonte 1
Pohang 1
Pune 1
Redwood City 1
San Giorgio A Cremano 1
Sarno 1
Seregno 1
Singapore 1
Slough 1
Stockholm 1
Sydney 1
Tel Aviv 1
Tokyo 1
Vicenza 1
Wuhan 1
Totale 913
Salva come PNG Salva come JPEG
Nome #
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 63
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma 51
Washout of 99mTc-Sestamibi in predicting response to chemotherapy in patients with multiple myeloma. 43
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma 43
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 42
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 41
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 39
Functional imaging of multidrug resistance in breast cancer. 39
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 38
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 38
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcima 36
99mTc-MIBI in the evaluation of breast cancer biology 36
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study 36
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 35
PET/CT in cancer research: from preclinical to clinical applications. 34
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma 34
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors 34
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma 33
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw 31
Nuclear imaging in cancer theranostic 30
A Survey of surgical Pathology of the medistinum preliminary data from a multicenter study”. 28
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma. 28
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 26
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 26
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma 26
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 26
Evidence of brown fat activity in constitutional leanness. 25
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 25
Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients 25
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 24
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 24
99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis. 24
Metabolic tumor volume assessed by 18F-FDG-PET/CT for the prediction of outcome in patients with multiple myeloma 23
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma 23
99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine 23
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 23
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. 22
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. 22
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 21
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives. 21
Combined imaging with 18F-FDG-PET/CT and 111In-labeled Octreotide SPECT for evaluation of thymic epithelial tumors 20
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3. 19
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma 19
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 19
In vitro receptor imaging for characterization of human solid tumors. 18
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 18
Preclinical imaging in targeted cancer therapies. 17
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells. 17
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 16
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC 16
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 15
SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer 15
Preclinical imaging for targeting cancer immune evasion 15
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. 14
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 14
PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients 14
Oncologia 13
Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma. 13
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. 11
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 10
PET/CT in radiation oncology 10
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by 18F-Fluorothymidine 9
Molecular Imaging of drug resistance in cancer. 8
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors. 8
What molecular imaging of cancer patients can teach us about COVID-19 7
A look into the future: the role of PSMA beyond prostate cancer 5
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay 3
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography 2
Coefficient of variation in metastatic lymph nodes determined by 18F-FDG PET/CT in patients with advanced NSCLC: combination with coefficient of variation in primary tumors 2
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? 2
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors 2
Sentinel lymph node identification in breast cancer patients 1
Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT 1
Totale 1.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 1 13
2019/2020189 74 0 9 7 13 8 4 0 12 12 28 22
2020/2021147 1 10 20 10 24 25 12 4 19 5 9 8
2021/2022346 7 1 7 1 7 9 6 7 48 14 88 151
2022/2023473 65 48 11 35 66 57 3 56 67 34 26 5
2023/2024276 16 42 39 23 23 15 19 71 14 13 1 0
Totale 1.634